Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Muscarinic receptor subtypes: implications for lung disease.

Literature DB >> 2650010

Muscarinic receptor subtypes: implications for lung disease.

P J Barnes¹.

Abstract

Entities: Disease

Mesh：

Substances：
Receptors, Muscarinic

Year: 1989 PMID： 2650010 PMCID： PMC461745 DOI： 10.1136/thx.44.3.161

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

37 in total

1. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.

Authors: R Hammer; A Giachetti
Journal: Life Sci Date: 1982-12-27 Impact factor: 5.037

2. Muscarinic receptors in lung and trachea: autoradiographic localization using [3H]quinuclidinyl benzilate.

Authors: P J Barnes; J A Nadel; J M Roberts; C B Basbaum
Journal: Eur J Pharmacol Date: 1982-12-17 Impact factor: 4.432

3. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes.

Authors: T I Bonner; A C Young; M R Brann; N J Buckley
Journal: Neuron Date: 1988-07 Impact factor: 17.173

4. Differential and selective antagonism of the slow-inhibitory postsynaptic potential and slow-excitatory postsynaptic potential by gallamine and pirenzepine in the superior cervical ganglion of the rabbit.

Authors: J H Ashe; C A Yarosh
Journal: Neuropharmacology Date: 1984-11 Impact factor: 5.250

5. Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors: R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal: Nature Date: 1980-01-03 Impact factor: 49.962

6. Effects of pirenzepine and atropine on vagal and cholinergic gastric secretion and gastrin release and on heart rate in the dog.

Authors: B I Hirschowitz; J Fong; E Molina
Journal: J Pharmacol Exp Ther Date: 1983-05 Impact factor: 4.030

7. Postganglionic muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig.

Authors: D Faulkner; A D Fryer; J Maclagan
Journal: Br J Pharmacol Date: 1986-05 Impact factor: 8.739

8. Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle.

Authors: L C Blaber; A D Fryer; J Maclagan
Journal: Br J Pharmacol Date: 1985-11 Impact factor: 8.739

9. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig.

Authors: A D Fryer; J Maclagan
Journal: Br J Pharmacol Date: 1984-12 Impact factor: 8.739

10. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat.

Authors: R Hammer; E Giraldo; G B Schiavi; E Monferini; H Ladinsky
Journal: Life Sci Date: 1986-05-05 Impact factor: 5.037

8 in total

Review 1. Respiratory diseases.

Authors: D G James; O M Sharma
Journal: Postgrad Med J Date: 1990-01 Impact factor: 2.401

Review 2. Molecular biology and respiratory disease. 5. Molecular biology of receptors: implications for lung disease.

Authors: P J Barnes
Journal: Thorax Date: 1990-06 Impact factor: 9.139

3. A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma.

Authors: C M Houghton; A A Woodcock; D Singh
Journal: Br J Clin Pharmacol Date: 2005-02 Impact factor: 4.335

Review 4. The role of anticholinergic antimuscarinic bronchodilator therapy in children.

Authors: M Silverman
Journal: Lung Date: 1990 Impact factor: 2.584

5. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.

Authors: D M Newnham; D P Dhillon; J H Winter; C M Jackson; R A Clark; B J Lipworth
Journal: Thorax Date: 1993-11 Impact factor: 9.139